Health-Related Quality of Life of Non-Small Cell Lung Cancer Patients Treated with Targeted Therapy: Based on the EQ-5D-5L Scale in Vietnam

Chinh Van Nguyen; Thi Hoa Nguyen; Tram Luu Nguyen; Linh Dao; Huong Tran Thi; Kiet Tuan Pham Huy

Asian Pacific Journal of Cancer Prevention · 2025 · Tập 26(4) · 1277-1283

DOI Trang nguồn Toàn văn RIS BibTeX

Tóm tắt

OBJECTIVE: Non-small cell lung cancer (NSCLC) patients can prolong their life owing to targeted therapy. Assessing patients' quality of life (QOL) can help improve QOL and prolong their lives. METHODS: A cross-sectional study was conducted at the Department of Medical Oncology 1 and Medical Oncology 2, Vietnam National Cancer Hospital in Tan Trieu, Hanoi, Vietnam, from October 2022 to December 2023 on the basis of the EQ-5D-5L scale to identify the QOL of 310 patients with NSCLC who were treated with first-line targeted therapy. Nonparametric tests and Tobit regression models were used to compare the differences and identify factors related to NSCLC patients' health-state utility. RESULTS: Pain/discomfort (80.6%) and anxiety/depression (75.2%) were the most common dimensions, especially among NSCLC patients experiencing side effects, with only 10.0% of patients reporting no problems. The EQ-5D-5L utility and EQ-VAS scores were 0.8255 and 64.39, respectively. The presence of side effects has been shown to decrease the quality of life for patients (Coef. = -0.04203, p < 0,001). Conversely, support from health insurance has been associated with improved quality of life, with 95% support of health insurance (Coef. = 0.0594, p = 0.001) and 100% support of health insurance (Coef. = 0.0318, p = 0.013) having positive effects. CONCLUSION: Health insurance support and side effects related to patients' health-state utility scores. Increasing health insurance support and improving side effects would help increase patients' QOL.

Nguyên văn tóm tắt của bài gốc đăng trên Asian Pacific Journal of Cancer Prevention.

Thông tin HTA

Thông tin thư mục do HERAC biên tập và đối chiếu với trang nguồn. Vui lòng đọc và trích dẫn tài liệu gốc.